Assay Design and Sample Collection Can Affect Anti-John Cunningham Virus Antibody Detection

被引：9

作者：

Goelz, Susan E. ^{[1
]}

Gorelik, Leonid ^{[1
,2
]}

Subramanyam, Meena ^{[3
]}

机构：

[1] Biogen Idec Inc, Dept Neurol, Cambridge, MA 02142 USA

[2] Biogen Idec Inc, Dept Mol Discovery, Cambridge, MA USA

[3] Biogen Idec Inc, Dept Clin Sci & Technol, Cambridge, MA USA

来源：

ANNALS OF NEUROLOGY | 2011年 / 69卷 / 02期

关键词：

PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RISK;

D O I：

10.1002/ana.22304

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：429 / 430

页数：2

共 3 条

[1] Anti-JC Virus Antibodies: Implications for PML Risk Stratification [J].

Gorelik, Leonid ;

Lerner, Michaela ;

Bixler, Sarah ;

Crossman, Mary ;

Schlain, Brian ;

Simon, Kenneth ;

Pace, Amy ;

Cheung, Anne ;

Chen, Ling Ling ;

Berman, Melissa ;

Zein, Fairuz ;

Wilson, Ewa ;

Yednock, Ted ;

Sandrock, Alfred ;

Goelz, Susan E. ;

Subramanyam, Meena .

ANNALS OF NEUROLOGY, 2010, 68 (03) :295-303

[2] JC Virus Persistence Following Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients Treated with Natalizumab [J].

Ryschkewitsch, Caroline F. ;

Jensen, Peter N. ;

Monaco, Maria Chiara ;

Major, Eugene O. .

ANNALS OF NEUROLOGY, 2010, 68 (03) :384-391

[3] Progressive Multifocal Leukoencephalopathy: Can We Reduce Risk in Patients Receiving Biological Immunomodulatory Therapies? [J].

Tyler, Kenneth L. .

ANNALS OF NEUROLOGY, 2010, 68 (03) :271-274

← 1 →